Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19

BACKGROUND: A significant portion of COVID-19 sufferers have asthma. The impacts of asthma on COVID-19 progression are still unclear but a modifying effect is plausible as respiratory viruses are acknowledged to be an important trigger for asthma exacerbations and a different, potentially type-2 bia...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Allergy Asthma Clin Immunol
Egile Nagusiak: Luo, Jian, Chen, Yi-Ling, Chen, Wentao, Duncan, David A., Mentzer, Alexander, Knight, Julian C., Ogg, Graham, Klenerman, Paul, Pavord, Ian D., Xue, Luzheng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264490/
https://ncbi.nlm.nih.gov/pubmed/34238349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-021-00569-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak